Economic Burden on Public Health Expenditure of Patients with Pre-dialysis Chronic Kidney Disease at a Community Hospital
Keywords:
Chronic kidney disease, Pre-dialysis, Costs, Economic burdenAbstract
Background : Chronic kidney disease (CKD) is an emerging non-communicable diseases which poses economic burden to the country.
Objective : This study aimed to compare the actual costs of care for patients with pre-dialysis chronic kidney disease at Khlong-Lan hospital.
Methods : A retrospective analysis was conducted by using Khlong-Lan hospital information database. All costs of resource utilization of patients who had been diagnosed with stage 3-5 Pre-dialysis CKD from January 1 to December 31, 2016 were collected. These include the followings costs: medicine, cost of hospitalization (if any), blood & blood components, laboratory and pathology investigations, diagnostic radiology and radiotherapy, special diagnostic tests, medical equipment services, procedure and anesthesia services, nursing services, physical therapy services and medical supplies. Costs estimation was done by using 2 different sources (1) unit cost of Khlong-Lan hospital and (2) a standard list of costs for community hospital.
Results : Data from 215 patients with stage 3-5 Pre-dialysis CKD were obtained. The costs were adjusted to the 2018 fiscal year costs. The mean total cost (per person per year) estimated with the standard list of cost for community hospital was 25% lower than that estimated with the unit cost of Khlong-Lan hospital (5,611 and 7,478 Thai Baht respectively).
Conclusion : The cost of health care for patients with pre-dialysis CKD estimated with the standard list of cost for community hospital yielded lower amount than that based on unit cost of Khlong-Lan hospital.
References
Rungprai D, Sukkha S, Chaijamorn W, Wanakamanee U, Onlamai K, Wongphira P. Handbook of kidney disease care for pharmacists. Bangkok: Prachachon; 2558. (In Thai)
National kidney foundation. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Inter Suppl 2013;3:1-150.
Ingsathit A, Thakkinstian A, Chaiprasert A, Sangthawan P, Gojaseni P, Kiattisunthorn K, et al. Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant 2010;25:1567-75.
Kefale B, Alebachew M, Tadesse Y, Engidawork E. Quality of life and its predictors among patients with chronic kidney disease: A hospital-based cross sectional study. PLoS One 2019;14:e0212184.
Rubio AR, Asencio JMM, Raventos MEP. Depression, anxiety and health-related quality of life amongst patients who are starting dialysis treatment. J Ren Care 2017;43:73-82.
Wyld MLR, Morton RL, Clayton P, Wong MG, Jardine M, Polkinghorne K, et al. The impact of progressive chronic kidney disease on healthrelated quality-of-life: a 12-year community cohort study. Qual Life Res 2019;28:2081-90.
Golestaneh L, Alvarez PJ, Reaven NL, Funk SE, McGaughey KJ, Romero A, et al. All-cause costs increase exponentially with increased chronic kidney disease stage. Am J Manag Care 2017;23 Suppl 10:S163-72.
Jiamjariyapon T, Ingsathit A, Pongpirul K, Vipattawat K, Kanchanakorn S, Saetie A, et al. Effectiveness of integrated care on delaying progression of stage 3-4 chronic kidney disease in rural communities of Thailand (ESCORT study): a cluster randomized controlled trial. BMC Nephrol 2017;18:83.
National Health Security Office. National health security fund management guide fiscal year 2019. Nonthaburi: Sahamitr printing and publishing; 2018. (In Thai)
Chaikledkaew U, Teerawattananon Y, Kongphitayachai S, Suksomboon N. Guidelines for health technology assessment in Thailand. Nonthaburi: The graphic system; 2009. (In Thai)
Health Intervention and Technology Assessment Program [internet]. Nonthaburi: Concept and costing method [cited 10 June 2017]. Available from: http://costingmenu.hitap.net/. (In Thai)
Kantachuvessiri S, Potisat S, Ngowsiri J. Guidelines for screening and care for kidney complications in patients with diabetes and hypertension. Nonthaburi: The agricultural cooperative federation of Thailand; 2012. (In Thai)
Strategy and planning division. International statistical classification of diseases and related health problems tenth revision Thai modification volumn 1. Bangkok: Sri Mueang Printing; 2016. (In Thai)
Riewpaiboon A. Standard cost lists for health technology assessment. Bangkok: Tanapress; 2011. (In Thai)
Permsuwan U. Health economic evaluation and budget impact analysis. Chiangmai: Research Administration Center, Chiang Mai University; 2018. (In Thai)
Drug and medical supply information center, ministry of public health [internet]. Nonthaburi: Drug price [cited 23 July 2018]. Available from: http://dmsic.moph.go.th/dmsic/index.php?p=1&id=1. (In Thai)
Riewpaiboon A. Standard cost lists for health economic evaluation in Thailand. J Med Assoc Thai 2014;97 Suppl 5:S127-34.
Srisubat A, Jiamjariyapon T, Chanpitakkul M, Leesmidt V, Wisansak W, Promnim S, et al. Cost effectiveness of integrated care in patients with chronic kidney disease stage 3 and 4 compared with standard care in rural communities. Journal of the Department of Medical Services 2017;42:54-63.
Downloads
Published
How to Cite
Issue
Section
License
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของกรมการแพทย์ กระทรวงสาธารณสุข
ข้อความและข้อคิดเห็นต่างๆ เป็นของผู้เขียนบทความ ไม่ใช่ความเห็นของกองบรรณาธิการหรือของวารสารกรมการแพทย์
